The DOI matches its Crossref record; 171 of the 171 references it cites were found in a registry or an index.
Disorders of Bone Remodeling
Open accessAbstract
The skeleton provides mechanical support for stature and locomotion, protects vital organs, and controls mineral homeostasis. A healthy skeleton must be maintained by constant bone modeling to carry out these crucial functions throughout life. Bone remodeling involves the removal of old or damaged bone by osteoclasts (bone resorption) and the subsequent replacement of new bone formed by osteoblasts (bone formation). Normal bone remodeling requires a tight coupling of bone resorption to bone formation to guarantee no alteration in bone mass or quality after each remodeling cycle. However, this important physiological process can be derailed by a variety of factors, including menopause-associated hormonal changes, age-related factors, changes in physical activity, drugs, and secondary diseases, which lead to the development of various bone disorders in both women and men. We review the major diseases of bone remodeling, emphasizing our current understanding of the underlying pathophysiological mechanisms.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“OPG, a soluble receptor also produced by osteoblasts that acts as a decoy receptor and neutralizes RANKL, prevents RANKL from interacting with RANK and consequently inhibits osteoclast proliferation, activity, and survival [73, 74].”
From The Effect of Tobacco Smoking on Bone Mass: An Overview of Pathophysiologic Mechanisms (2018) · cites this paper as [73]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Once RANKL binds to its natural receptor, expressed by osteoclast precursor cells, it stimulates osteoclast precursor differentiation to active mature osteoclasts and accelerates bone resorption [73].”
From The Effect of Tobacco Smoking on Bone Mass: An Overview of Pathophysiologic Mechanisms (2018) · cites this paper as [73]
In the citing paper
“Abnormal increase in osteoclast formation and activity leads to some bone diseases such as osteoporosis, where resorption exceeds formation causing decreased bone density and increased bone fractures [105].”
From Biology of Bone Tissue: Structure, Function, and Factors That Influence Bone Cells (2015) · cites this paper as [105]
In the citing paper
“In patients with chronic liver disease, the balance between osteoclasts and osteoblasts is affected by liver disease, resulting in BRU imbalance [46,50].”
From Bone diseases in patients with chronic liver disease (2019) · cites this paper as [46]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Oxidants, oxidative stress and the biology of ageing
Finkel, T., & Holbrook, N. J. (2000) · Nature · doi:10.1038/35041687 · Cited by 9,413
Osteoclast differentiation and activation
Boyle, W. J., Simonet, W. S., & Lacey, D. L. (2003) · Nature · doi:10.1038/nature01658 · Cited by 6,670
Osteoporosis Prevention, Diagnosis, and Therapy
NIH Consensus Development Panel on Osteoporosis Prevention, D. (2001) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.285.6.785 · Cited by 5,529
Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation.
Lacey, D. L., Timms, E., Tan, H.-L., Kelley, M. J., Dunstan, C. R., Burgess, T., Elliott, R., Colombero, A., Elliott, G., Scully, S., et al. (1998) · Cell · doi:10.1016/s0092-8674(00)81569-x · Cited by 5,439
Osteoprotegerin: a novel secreted protein involved in the regulation of bone density.
Simonet, W. S., Lacey, D. L., Dunstan, C. R., Kelley, M., Chang, M.-S., Lüthy, R., Nguyen, H. Q., Wooden, S., Bennett, L., Boone, T., et al. (1997) · Cell · doi:10.1016/s0092-8674(00)80209-3 · Cited by 5,130
Mitochondria, Oxidants, and Aging
Balaban, R. S., Nemoto, S., & Finkel, T. (2005) · Cell · doi:10.1016/j.cell.2005.02.001 · Cited by 4,388
Yasuda, H., Shima, N., Nakagawa, N., Yamaguchi, K., Kinosaki, M., Mochizuki, S.-I., Tomoyasu, A., Yano, K., Goto, M., Murakami, A., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.7.3597 · Cited by 4,224
Bone Resorption by Osteoclasts
Teitelbaum, S. L. (2000) · Science · doi:10.1126/science.289.5484.1504 · Cited by 3,962
OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph node organogenesis.
Kong, Y.-Y., Yoshida, H., Sarosi, I., Tan, H.-L., Timms, E., Capparelli, C., Morony, S., Oliveira-dos-Santos, A. J., Van, G., Itie, A., et al. (1999) · Nature · doi:10.1038/16852 · Cited by 3,351
Manolagas, S. C. (2000) · Endocrine Reviews · doi:10.1210/edrv.21.2.0395 · Cited by 2,639
Research works printed but not linked: 11
- McGowen JA, 2004, Bone Health and Osteoporosis: A Report of the Surgeon General, 69
- Raisz LG., 1988, Ciba Found. Symp., 136, 226
- Mundy GR., 1991, Ciba Found. Symp., 157, 137
- Andersen TL, 2009, Br. J. Haematol., 48, 551
- Heaney RP, 1978, J. Lab. Clin. Med., 92, 964
- 10.1210/en.142.6.2205 · DOI · Paper page
- 10.1172/JCI200317215 · DOI · Paper page
- 10.1210/jc.83.12.4257 · DOI
- Peretz A, 1989, J. Rheumatol., 16, 363
- Takata S, 2001, J. Med. Investig., 48, 147
- Block GA, 2006, Clinical Guide to the Basics of Bone and Mineral Metabolism in CKD, 77
Cited by
Sorted by citations
Items 901–1,000 of 1,000
Osteocytic vinculin controls bone mass by modulating Mef2c-driven sclerostin expression in mice
Wang, Y., Huang, J., Lin, S., Qin, L., Hao, D., Zhang, P., Huo, S., Zou, X., Chen, D., & Xiao, G. (2025) · Bone Research · doi:10.1038/s41413-025-00452-x · Cited by 4
Zhang, S., Zeng, Y., Zhang, S., Zhou, J., Liu, C., & Chen, X. (2025) · Nano Letters · doi:10.1021/acs.nanolett.5c04029 · Cited by 4
Luo, L., Cao, H., Zhou, L., Zhang, G., & Wu, L. (2023) · Biomaterials Advances · doi:10.1016/j.bioadv.2023.213634 · Cited by 4
Park, J., Kim, S., Jung, H.-Y., Bae, E., Shin, M., Park, J.-I., Choi, S., Yi, S.-J., & Kim, K. (2024) · iScience · doi:10.1016/j.isci.2024.111455 · Cited by 4
Wen, S., Liao, X., Chang, R., & Wang, S. (2025) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2025.108568 · Cited by 5
Lee, J., Oh, J., Kim, J. R., Ha, H., Kim, T., & Jeong, D. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26157123 · Cited by 5
“Since bone remodeling is regulated by osteoclast-mediated bone resorption followed by osteoblast-mediated bone formation [23], we investigated the effects of cabozantinib on osteoblast and osteoclast differentiation.”
Zhao, C., Wu, F., Zhao, L., Zhong, J., Huang, C., Jiang, Z., Zheng, J., Yang, S., Zhang, C., & Zhang, L. (2025) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2025.10.284 · Cited by 4
Rodrigues, B. M., Mathias, L. S., Deprá, I. C., Cury, S. S., de Oliveira, M., Olímpio, R. M. C., Síbio, M. T. D., Gonçalves, B. M., & Nogueira, C. R. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.886136 · Cited by 4
“Additionally, osteoblasts control bone remodeling by modulating osteoclastogenesis and bone resorption by the osteoclasts (Hadjidakis and Androulakis, 2006; Feng and McDonald, 2011; Boyce et al., 2012; Hayden et al., 2014).”
BackgroundShao, C., Liu, Y., Zhao, Y., Jing, Y., Li, J., Lv, Z., Fu, T., Wang, Z., & Li, G. (2023) · Bone · doi:10.1016/j.bone.2023.116706 · Cited by 4
Wu, T., Tsou, Y., Wu, W., Lee, R., Wang, J., & Yeh, K. (2023) · The Journal of Clinical Pharmacology · doi:10.1002/jcph.2378 · Cited by 4
“14,15 Diabetes, rheumatoid arthritis, and smoking may affect this pathway and result in poor bone health among older adults.”
BackgroundBeneath the Surface: Exploring Hidden Threats of Long-Term Corticosteroid Therapy to Bone Density
Alfaedi, S. A., Kubbara, M., Alaithan, A. A., Alhudhaif, H. M., Abdullah, A. A. A., Sahool, H. M., Jawad, M. S. A., Almatar, M. A., Alnakhli, I. R., & Altawili, M. A. (2024) · Cureus · doi:10.7759/cureus.55109 · Cited by 4
“The orchestrated interplay between these cellular activities is governed by a complex network of signalling pathways, hormonal regulation, and local factors, all contributing to the maintenance of bone homeostasis [26,27].”
BackgroundMcCandless, B. A., Raum, K., & Muller, M. M. (2024) · Physics in Medicine and Biology · doi:10.1088/1361-6560/ad3fff · Cited by 4
[Research Progress in the Regulatory Role of circRNA-miRNA Network in Bone Remodeling].
Lan, Y., Yu, L., Hu, Z., & Zou, S. (2024) · PubMed Central · doi:10.12182/20240360301 · Cited by 4
Multiple applications of metal-organic frameworks (MOFs) in the treatment of orthopedic diseases
Zhao, Z., Wang, C.-X., Liu, A., Bai, N., Jiang, B.-X., Mao, Y., Ying, T., Dong, D.-M., Yi, C., & Li, D.-J. (2024) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2024.1448010 · Cited by 3
“In other pathological conditions, resorption occurs independently from subsequent bone formation leading to destructive bone loss (Feng and Mcdonald, 2011).”
BackgroundEffects of Aging and Exercise Training on Bone Vascular Function and Structural Adaptations
Park, H., Narayanan, S. A., Caldwell, J. T., Behnke, B. J., Muller‐Delp, J. M., & Delp, M. D. (2024) · Bone · doi:10.1016/j.bone.2024.117335 · Cited by 4
Catharanthine tartrate ameliorates osteoclastogenesis by destabilizing HIF-1α
Cai, L., Yu, C., Zhao, B., Wu, Q., Liang, H., Zhou, M., Miao, J., Luo, J., Xu, J., Jin, H., et al. (2025) · Cellular Signalling · doi:10.1016/j.cellsig.2025.111779 · Cited by 4
Moura, S. R., Olesen, J. B., Lindberg‐Larsen, M., Barbosa, M. A., Søe, K., & Almeida, M. I. (2025) · Cell Communication and Signaling · doi:10.1186/s12964-025-02324-7 · Cited by 5
“Disruptions in any phase of bone remodelling, caused by several intrinsic or extrinsic factors can adversely affect subsequent phases, influencing the onset of various bone-related diseases [9].”
Shchukarev, A., Ransjö, M., & Mladenovi, Z. (2011) · InTech eBooks · doi:10.5772/24578 · Cited by 4
Bioactive Molecules and Their Mechanisms of Action
Wang, D., Heiß, E. H., Šmejkal, K., & Atanasov, A. G. (2019) · Molecules · doi:10.3390/molecules24203752 · Cited by 4
MicroRNAs as Next Generation Therapeutics in Osteoporosis
Kaur, T., Kapila, R., & Kapila, S. (2020) · IntechOpen eBooks · doi:10.5772/intechopen.91223 · Cited by 4
“Osteoporosis is regarded as a silent bone disorder.”
BackgroundInfluentialImpact of Single or Combined Drug Therapy on Bone Regeneration in Healthy and Osteoporotic Rats
Shaheen, M. Y., Basudan, A. M., Niazy, A. A., van den Beucken, J. J. J. P., Jansen, J. A., & Alghamdi, H. S. (2020) · Tissue Engineering Part A · doi:10.1089/ten.tea.2020.0122 · Cited by 4
Jang, S., Hwang, Y., Yang, H. J., Ryuk, J. A., Gu, D. R., & Ha, H. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.112640 · Cited by 4
Exosomes: Mediators of bone diseases, protection, and therapeutics potential
(2018) · Oncoscience · doi:10.18632/oncoscience.409 · Cited by 4
Chen, Y., Zheng, G., Bian, Y., Ma, H., Jin, C., Hu, Z., Su, H., Hu, X., Qian, Z., Shen, L., et al. (2022) · Applied Materials Today · doi:10.1016/j.apmt.2022.101530 · Cited by 4
Jin, L., Huo, S., Guo, C. Y., Liu, H.-Y., Xu, S., & Li, X. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/3458560 · Cited by 4
“Abnormal activities of OB and OC could result in development and progression of various bone disorders, such as osteoporosis (OP) [2, 3].”
BackgroundBone biology and microscopic changes in response to behaviour
DeMars, L. J. D., Torres‐Tamayo, N., Hirst, C. S., & Miszkiewicz, J. J. (2023) · Elsevier eBooks · doi:10.1016/b978-0-12-821383-4.00009-7 · Cited by 6
NaF18-PET/CT Imaging of Secondary Hyperparathyroidism
Win, A. Z., & Aparici, C. M. (2015) · Nuclear Medicine and Molecular Imaging · doi:10.1007/s13139-015-0319-3 · Cited by 4
“The incidence of renal osteodystrophy is unknown, but almost 325,000 Americans are on dialysis therapy [2].”
BackgroundFall Incidence and Risk Factors in Hemodialysis Patients
Yekta, A. H. A., Fatollahierad, S., Hassabi, M., Falaknazi, K., Khosravi, S., & Poursaeed, M. (2016) · Turkish Journal of Nephrology · doi:10.5262/tndt.2016.1003.08 · Cited by 4
“Many of the symptoms of hyperparathyroidism are not distinct and consist of pain in joints, spontaneous tendon rupture, susceptibility to fracture, proximal muscle weakness (31) and high turnover bone remodeling (32).”
BackgroundИммунологические аспекты постменопаузального остеопороза
Povoroznyuk, V. V., Резниченко, Н. А., & Maylyan, E. A. (2019) · PAIN JOINTS SPINE · doi:10.22141/2224-1507.3.11.2013.82325 · Cited by 4
Ma’arif, B., Suryanto, S., Muslikh, F. A., Suryadinata, A., & Fauziyah, B. (2022) · Journal of Pharmaceutical Sciences and Community · doi:10.24071/jpsc.003166 · Cited by 4
Maksud, F. A. N., Kakehasi, A. M., Guimarães, M. F. B. D. R., Machado, C. J., & Barbosa, A. J. A. (2017) · Brazilian Journal of Medical and Biological Research · doi:10.1590/1414-431x20175977 · Cited by 4
“Also, mechanical stresses can cause disruption of the remodeling bone process, leading to low bone mass with increased fragility and fractures (7).”
BackgroundAmorim, T., Metsios, G. S., Flouris, A. D., Nevill, A. M., Gomes, T. N., Wyon, M. A., Marques, F., Nogueira, L., Adubeiro, N., Jamurtas, A. Z., et al. (2019) · Archives of Osteoporosis · doi:10.1007/s11657-019-0596-z · Cited by 4
“Bone tissue is constantly renewed by the coordinated activity of osteoclasts (bone-resorbing cells) and osteoblasts (bone-forming cells) in a process known as bone remodelling [1].”
BackgroundClinical Implementation of Bone Regeneration and Maintenance
Barbeck, M., Rosenberg, N., Kačarević, Ž. P., Jung, O., & Rider, P. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.85328 · Cited by 4
Tocotrienol: An Underrated Isomer of Vitamin E in Health and Diseases
Musa, A. F. (2021) · Biochemistry · doi:10.5772/intechopen.96451 · Cited by 4
Frequent, quantitative bone planar scintigraphy for determination of bone anabolism in growing mice
Zaloszyc, A., Schmitt, C. P., Sayeh, A., Higel, L., Gros, C. I., Bornert, F., Aubertin-Kirch, G., Dillenseger, J., Goetz, C., Constantinesco, A., et al. (2021) · PeerJ · doi:10.7717/peerj.12355 · Cited by 4
Natural Polymeric Hydrogels in Chondral/Osteochondral Tissue Engineering
Byram, P. K., Das, L., Dhara, S., & Chakravorty, N. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-820352-1.00097-3 · Cited by 4
González-Henríquez, C. M., Sarabia‐Vallejos, M. A., Sanz-Horta, R., & Rodríguez‐Hernández, J. (2022) · Wiley eBooks · doi:10.1002/9783527815562.mme0040 · Cited by 4
Anti-osteoporotic effects of Boswellia serrata gum resin extract in vitro and in vivo
Lee, H. S., Jung, J. I., Hong, I. K., Jang, Y., Kim, H.-B., & Kim, E. J. (2024) · Nutrition Research and Practice · doi:10.4162/nrp.2024.18.3.309 · Cited by 3
“In normal bone remodeling, the balance between bone resorption and formation is controlled by cooperative cell signaling [26].”
BackgroundInfluentialIntegrative analyses of genetic mechanisms responsible for bone–fat imbalance in osteoporosis
Zhang, Z., Tao, Z., Zhang, Y., Zhang, Z., Zhang, W., Zhang, X., Zhao, J., Tao, C., & Zhou, X. (2024) · The Journal of Gene Medicine · doi:10.1002/jgm.3739 · Cited by 3
Kalc, P., Hoffstaedter, F., Eileen Luders, A., Gaser, C., & Dahnke, R. (2024) · Imaging Neuroscience · doi:10.1162/imag_a_00390 · Cited by 5
“Bone tissue undergoes constant remodelling which is supported by osteoclasts (i.e., bone resorbing cells) and osteoblasts (i.e., new bone-forming cells) to regulate mineral homeostasis and ensure skeletal integrity (Clarke 2008; Feng and McDonald 2011).”
BackgroundStasek, S., Reincke, S., Rehberg, M., Semler, O., & Hoyer‐Kuhn, H. (2025) · JBMR Plus · doi:10.1093/jbmrpl/ziaf140 · Cited by 3
“36,37 Furthermore, Liu et al.’s study demonstrated similar effectiveness with 6-mo intervals of denosumab compared to standard therapy with zole-dronate, suggesting that a 6 mo interval of denosumab is sufficient to increase bone mass in children with OI.”
A Novel RANKL/RANK Inhibitor IMB-R38 Inhibits Osteoporosis Through Regulating Bone Metabolism
Zhang, Y., Wei, X., Sheng, R., Yang, G., Han, X., Wang, J., Liu, C., Li, S., Lei, L., Jiang, W., et al. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262412151 · Cited by 3
“Bone remodeling is a cyclic metabolic process mediated by OC-induced bone resorption and osteoblast (OB)-mediated bone formation, maintaining the homeostasis of bone architecture [12,13].”
Regulation of Osteoblast to Osteocyte Differentiation by Cyclin‐Dependent Kinase‐1
Tanaka, T. N., Miyakoshi, Y., Kobayashi, Y., Sun, X., Yu, D., Ochi, H., Sato, S., Kato, T., Yoshii, T., Okawa, A., et al. (2023) · Advanced Biology · doi:10.1002/adbi.202300136 · Cited by 3
Su, P., Luo, X., Zeng, C., & Zhou, L. (2023) · Rheumatology & autoimmunity · doi:10.1002/rai2.12088 · Cited by 3
Astleford, K., Abrahante, J. E., Bradley, E. W., & Mansky, K. C. (2024) · JBMR Plus · doi:10.1093/jbmrpl/ziae142 · Cited by 6
Pim1 promotes the maintenance of bone homeostasis by regulating osteoclast function
Seo, J., Ko, R., Kim, M., Seo, J., Lee, H., Kim, D., Jeong, W., Kim, H. S., & Lee, S. Y. (2025) · Experimental & Molecular Medicine · doi:10.1038/s12276-025-01421-4 · Cited by 3
“This primarily involves the resorption of old bone by osteoclasts and the creation of new bone by osteoblasts 1,2 .”
Agarwal, S., Singh, A., Kumar, S., Rokade, T. P., Goswami, C., & Goswami, L. (2025) · Materials Advances · doi:10.1039/d4ma01178c · Cited by 3
Elmorsy, E. M., Doghaither, H. A. A., Al-Ghafari, A. B., Ebrahim, N. A., Mohamed, M. E. M., Ibrahim, S. F., Elgendy, F. S., & Abdeen, A. (2025) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2025.117491 · Cited by 3
Genetic Dissection of Trabecular Bone Structure with Mouse Intersubspecific Consomic Strains
Kataoka, T., Tamura, M., Maeno, A., Wakana, S., & Shiroishi, T. (2017) · G3 Genes Genomes Genetics · doi:10.1534/g3.117.300213 · Cited by 3
“Anexcess of bone resorption in imbalanced bone remodelingmanifests as reduced bone mineral density (BMD), and microstructural deterioration of trabecular bone eventually causes bone diseases such as osteoporosis (Feng and McDonald 2011).”
BackgroundÇevik, M. Ö., Korkusuz, P., & Korkusuz, F. (2020) · TURKISH JOURNAL OF MEDICAL SCIENCES · doi:10.3906/sag-2001-268 · Cited by 3
“This regenerative process of bone remodeling depends on the formative and resorptive activities of specialized bone cells called osteoblasts and osteoclasts [1].”
BackgroundThe physiology of disuse, immobilization and low-load environments
Clark, N. C., Glaister, M., Cannon, L. M., & Perrem, N. (2020) · Elsevier eBooks · doi:10.1016/b978-0-7020-7489-9.00003-x · Cited by 3
Topolska, K., Bieńko, M., Ptaszek, P., Florkiewicz, A., Radzki, R. P., & Filipiak‐Florkiewicz, A. (2022) · Animals · doi:10.3390/ani12091134 · Cited by 3
“It is crucial to maintain a healthy skeleton across the lifespan [28].”
BackgroundG‑CSF delays tooth extraction socket bone healing via the inhibition of bone turnover in mice
Oshitani, M., Takaoka, K., Ueta, M., Tomimoto, K., Hattori, H., Yoneda, N., Yamanegi, K., Noguchi, K., & Kishimoto, H. (2023) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2023.11803 · Cited by 3
Liu, X., Xu, X., Li, J., Shi, L., Zeng, Y., Tang, S., Liu, W. X., Jia, L., Li, Y., & Zhang, J. (2023) · Bioscience Biotechnology and Biochemistry · doi:10.1093/bbb/zbad075 · Cited by 3
Muttanahally, K. S., & Tadinada, A. (2023) · Cureus · doi:10.7759/cureus.42830 · Cited by 3
“Studies showed that 70-100/10,000 persons treated with these medications are affected by MRONJ [3,4].”
BackgroundOsteoblastogenesis and osteolysis in the Zucker Diabetic Sprague Dawley rat humerus head
Dlamini, G. F., & Ndou, R. (2023) · Anatomy & Cell Biology · doi:10.5115/acb.23.166 · Cited by 3
Application of Artificial Intelligence in Different Fields of Oromaxillofacial Surgery
Arian, Y. (2023) · Digital Medicine and Healthcare Technology · doi:10.5772/dmht.20 · Cited by 3
Sultan, H. H., Grisan, E., Dryburgh, P. R., Peralta, L. M., & Harput, S. (2024) · IEEE Access · doi:10.1109/access.2024.3404644 · Cited by 3
DEC1 deficiency protects against bone loss induced by ovariectomy by inhibiting inflammation
Lin, L., Qiang, Z., Chen, K., Huo, Y., Liu, W., & Yang, J. (2024) · Journal of Biomedical Research · doi:10.7555/jbr.38.20240069 · Cited by 3
Xu, C., Wei, Z., Lv, L., Dong, X., Xia, W., Xing, J., Liu, H., Zhao, X., Liu, Y., Wang, W., et al. (2024) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2024.150317 · Cited by 3
Shen, E., Piao, M., Li, Y., Wu, Y., Li, S., Lee, S. H., Jin, L., & Lee, K. Y. (2024) · Cells · doi:10.3390/cells13161352 · Cited by 3
“However, imbalances in osteoclast and osteoblast activity can lead to bone diseases, such as osteoporosis [14].”
BackgroundNEDD4 family E3 ligases in osteoporosis: mechanisms and emerging potential therapeutic targets
Wu, H., Zuo, J.-H., Dai, Y., Li, H., & Wang, S. (2025) · Journal of Orthopaedic Surgery and Research · doi:10.1186/s13018-025-05517-5 · Cited by 3
“Bone remodeling is a physiological process wherein osteoclasts first remove old or damaged bone, which is subsequently replaced by new bone formed by osteoblasts [46].”
Zhou, B. O., Huang, H., Ding, Z., Luo, K., Chen, Y., Han, Y., Pang, W., Tang, W., Chen, L., Jin, W., et al. (2025) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-025-05597-w · Cited by 4
“The association between OLCs and BMD, highlighted their potential involvement in age-related osteoporosis [10].”
Pham, N.-T., Peng, B., Le, H.-G., Cheng, Y.-S., Chen, Y.-S., Huynh, T. H., Chen, L.-Y., Nguyen, L. A. T., Nguyen, D. T., Chang, Y., et al. (2025) · Journal of Natural Products · doi:10.1021/acs.jnatprod.5c00457 · Cited by 3
Regulation of Osteoclastogenesis by Osteocytes through Growth Differentiation Factor-15
Hinoi, E. (2014) · YAKUGAKU ZASSHI · doi:10.1248/yakushi.14-00209-4 · Cited by 3
Regulation des Knochenstoffwechsels durch den Wnt-Signalweg
Houschyar, K. S., Tapking, C., Duscher, D., Harati, K., Wallner, C., Wagner, J. M., Maan, Z. N., Rein, S., Chelliah, M. P., Reumuth, G., et al. (2018) · Handchirurgie · Mikrochirurgie · Plastische Chirurgie · doi:10.1055/a-0642-1830 · Cited by 3
Biophysics and the nonlinear dynamics instigated by a special hormone
Javed, S., Sohail, A., Asif, A., & Nutini, A. (2019) · Progress in Biophysics and Molecular Biology · doi:10.1016/j.pbiomolbio.2019.05.005 · Cited by 3
Fauziah, H., Sumarsongko, T., & Azhari, A. (2020) · Jurnal Kedokteran Gigi Universitas Padjadjaran · doi:10.24198/jkg.v32i2.26570 · Cited by 3
Yali, Z., Wang, X., Xin, M., & Zhuang, H. (2021) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2021.10049 · Cited by 4
The Histochemistry and Cell Biology omnium-gatherum: the year 2015 in review
Taatjes, D. J., & Roth, J. (2016) · Histochemistry and Cell Biology · doi:10.1007/s00418-016-1417-8 · Cited by 3
“Bone remodeling involves a fine balance between resorption and deposition of bones, and bone remodeling disorders may result from hormonal imbalances, malnutrition, and age (Feng and McDonald 2011).”
Studying Bone Remodelling and Tumour Growth for Therapy Predictive Control
Miranda, R., Vinga, S., & Valério, D. (2020) · Mathematics · doi:10.3390/math8050679 · Cited by 3
Lee, J., Ahn, S. H., Chen, Z., Kang, S., Choi, D. K., Moon, C., Min, S. H., Park, B., & Lee, T. (2020) · Molecules · doi:10.3390/molecules25204855 · Cited by 3
“Bone homeostasis is a tightly regulated process that is associated with the balance between osteoblast and osteoclast activity; together, these activities maintain bone mass and mineral homeostasis [31].”
BackgroundPovoroznyuk, V. V., Dedukh, N. V., Bystrytska, M. А., & Shapovalov, V. S. (2021) · Regulatory Mechanisms in Biosystems · doi:10.15421/022130 · Cited by 4
“…bone remodeling cycle The bone remodeling cycle is usually considered to involve four stages: activation, resorption, reversal and formation (Feng & McDonald, 2011) or additionally two more stages are distinguished, namely the resting stage (resting bone) preceding the activation stage and…”
BackgroundKang, N. (2012) · TSpace (University of Toronto) · Cited by 3
3D Printed Marine Biomaterials Composites for Bone Tissue Engineering
Heo, S., Oh, G., & Jung, W. (2020) · Encyclopedia of Marine Biotechnology · doi:10.1002/9781119143802.ch54 · Cited by 3
Thiyagarajan, R., González, M. R., Zaw, C., Seldeen, K. L., Hernandez, M., Pang, M., & Troen, B. R. (2020) · Research Square · doi:10.21203/rs.3.rs-125262/v1 · Cited by 3
“During osteoporosis, osteoclastic bone resorption overwhelms bone formation leading to loss of bone mass and increased fragility [22].”
BackgroundNutraceutical Benefits for Bone Health: Role in Osteoporosis PreventionPreprint
Roseti, L., Borciani, G., Grassi, F., Desando, G., Gambari, L., & Grigolo, B. (2023) · Preprints.org · doi:10.20944/preprints202311.1546.v1 · Cited by 3
Influence of gut microbiome on metabolic diseases: a new perspective based on microgravity
Wu, W., Ren, J., Han, M., & Huang, B. (2024) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-024-01394-7 · Cited by 2
“However, in the microgravity environment, such as during space travel, astronauts experience an increase in serum NF-kB levels, indicating a decrease in SCFAs and other gut micro-biome metabolites [43].”
Choi, B. B. R., Park, S.-R., & Kim, G. (2024) · Medicina · doi:10.3390/medicina60081318 · Cited by 2
“Additionally, hormonal imbalances during bone remodeling can lead to bone loss [6] Consequently, maintaining bone homeostasis, which requires a balance between osteoblasts (bone-forming cells) and osteoclasts (bone-absorbing cells), is crucial for preventing osteoporosis [7].”
BackgroundMetabolic Bone Disease in Captive Flying Foxes: A Comprehensive Survey Across Zoological Parks
Faim, D., Silva, F. C., Weissenbacher, A., Starnberger, I., & Pires, I. C. R. (2025) · Veterinary Sciences · doi:10.3390/vetsci12030271 · Cited by 2
“Metabolic bone disease (MBD) is characterized by extreme bone remodeling, leading to calcium depletion at the bone level or hypomineralization [16].”
In Vivo quantification of 4D modeling and remodeling in trabecular and cortical bone microstructure
Shyu, P. T., Robinson, S. T., & Guo, X. (2025) · Frontiers in Medical Engineering · doi:10.3389/fmede.2025.1547895 · Cited by 2
Camassa, J. A. D. A., BARROS, V. A., Babo, P. S., Pereira, F. A. M., Morais, J. J. L., Fertuzinhos, A., de Azevedo, J. M. T., Reis, R. L., Gomes, M. E., Martins‐Bessa, A., et al. (2025) · Biology · doi:10.3390/biology14081031 · Cited by 2
Yuan, H., Bao, Y., Li, L., Luan, Y., & Li, F. (2025) · Archives of Gerontology and Geriatrics · doi:10.1016/j.archger.2025.106020 · Cited by 2
Lai, L., Li, K., Ding, L., Zhu, R., Jiang, Y., Xia, T., Yue, X., & Xin, H. (2025) · Fitoterapia · doi:10.1016/j.fitote.2025.106892 · Cited by 2
The Role of Glucose-Dependent Insulinotropic Polypeptide (GIP) in Bone Metabolism
Lin, A., Kitaura, H., Ohori, F., Marahleh, A., Ma, J., Fan, Z., Narita, K., Murakami, K., & KANETAKA, H. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27020600 · Cited by 2
“Mechanistically, estrogen deficiency upregulates RANKL and pro-inflammatory cytokines such as TNF-α , interleukin-1 (IL-1), and interleukin-6 (IL-6); decreases osteoprotegerin (OPG); prolongs osteoclast survival; increases sclerostin expression; and promotes osteoblast and osteocyte apoptosis [74].”
Jiang, H.-S., Liang, S., Chou, Y., & Angata, T. (2026) · Cell Reports · doi:10.1016/j.celrep.2025.116880 · Cited by 2
Advances in Bone-on-a-Chips for In Vitro Modeling of Bone Physiology and Pathology
Cheng, X., Lu, M., Ma, M., Zhou, S., Xu, J., Li, Y., & Lu, H. (2026) · Biomedicines · doi:10.3390/biomedicines14030710 · Cited by 2
Maggio, M., Martins, C., Almasri, R., Petrousek, S. R., Brunet, M. Y., Madden, L., Görgün, C., Néill, T. N., Roche, F. M., Buckley, C. T., et al. (2026) · Molecular Therapy · doi:10.1016/j.ymthe.2026.04.054 · Cited by 2
“1 However, disruption of this balance can result in abnormal remodeling, resulting in bone pathologies such as osteoporosis and osteopetrosis.”
Bone Development in Children and Adolescents
Boyanov, M. (2016) · Springer eBooks · doi:10.1007/978-3-319-32122-6_6 · Cited by 3
Tamgadge, S., & Tamgadge, A. P. (2018) · Dental Hypotheses · doi:10.4103/denthyp.denthyp_72_18 · Cited by 2
“If left unchecked over a long period of time, it can lead to osteoporosis of bone and demineralization in the teeth.([7])”
BackgroundChitosan based bionanocomposites in osteoporosis
Niranjan, M. K., Baghel, K., & Azam, Z. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-821280-6.00014-3 · Cited by 2
Nasulewicz‐Goldeman, A., Goldeman, W., Nikodem, A., Nowak, M., Papiernik, D., Goszczyński, T. M., & Wietrzyk, J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22179590 · Cited by 2
“Osteoporosis is a skeletal disorder characterized by the imbalance between bone formation and resorption, which leads to a decrease in bone mass and density and to progressive changes in bone structure [1].”
BackgroundDall’Ara, E., & Cheong, V. S. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-824481-4.00007-x · Cited by 4
Prosthodontic management in residual ridge resorption
Vasudeva, D. (2021) · International Journal of Health Sciences · doi:10.53730/ijhs.v5ns2.5633 · Cited by 2
Kim, A. R., Lee, Y. S., Kim, M., Kang, D., Bak, E., & Yoo, Y. (2022) · Oral Diseases · doi:10.1111/odi.14307 · Cited by 2
Bioactive constituents and potential health benefits of fermented seed products
Gandhi, G. R., Li, H., Vasconcelos, A. B. S., Montalvão, M. M., de Franca, M. N. F., He, X.-Q., Rong, P.-X., Li, H., & Gan, R. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-98341-9.00016-5 · Cited by 2
Lee, S.-Y., Kim, M. J., Ahn, S. I., Choi, S. K., Min, K. Y., Choi, W. S., & You, J. S. (2023) · Bone · doi:10.1016/j.bone.2023.116918 · Cited by 2
Chen, H.-W., Chen, C., Lee, P., Yiin, S.-J., Liang, J.-Y., Hsu, J., Chang, C., & Chern, C. (2023) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2023.129500 · Cited by 2
Harold, R. E., Sweeney, P. T., Torchia, M. T., & Kramer, J. (2024) · Seminars in Arthroplasty JSES · doi:10.1053/j.sart.2023.12.011 · Cited by 2
Li, Y., Liu, C., Han, X., Sheng, R., Li, B., Lei, L., Wu, Y., Li, Q., Zhang, Y., Zhang, J., et al. (2024) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2024.107364 · Cited by 2
Metadata
- Authors
- Feng, X., & McDonald, J. M.
- Affiliations
- University of Alabama at Birmingham (US)
- ORCID
- Feng, Xu
- Venue
- Annual Review of Pathology: Mechanisms of Disease
- Publisher
- Annual Reviews
- Published
- 2011-02-28
- Volume
- 6
- Issue
- 1
- Pages
- 121-145
- ISSN
- 1553-4006 (ISSN-L)
- 1553-4014
- PMC
- PMC3571087
- OpenAlex
- W2166266977
- Cited by
- 1,272
- References
- 171
- Citations by year
- 2026: 59 · 2025: 109 · 2024: 102 · 2023: 124 · 2022: 135 · 2021: 142 · 2020: 107 · 2019: 117 · 2018: 86 · 2017: 68 · 2016: 59 · 2015: 47 · 2014: 36 · 2013: 37 · 2012: 29
- FWCI
- 3.28
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Annual Review of Pathology Mechanisms of Disease (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Cancer Institute (R01CA109119)
- National Institute of Neurological Disorders and Stroke (R21NS061677, NS061677)
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (5P30 AR0406031, R01AR047830, AR 47830, R01AR050235)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
- Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
- Health Sciences › Medicine › Oncology › Bone health and treatments
- Keywords
- bone remodeling, bone resorption, bone formation, osteoclasts, osteoblasts, bone disease, menopause, hormonal changes, age-related bone loss, physical activity, drug-induced bone loss, mineral homeostasis, pathophysiology
- MeSH terms
- Animals, Bone Diseases, Humans, Bone Remodeling
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review